| Mepha Pharma AG - Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten | | 68440 | | 01 | | Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten | | | | B01AF01 | | Rivaroxaban | | 06.04.2022 | | |
| | Composition | | rivaroxabanum 2.5 mg, natrii laurilsulfas, lactosum monohydricum 184.7 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium max. 1.19 mg. | | Packungsbestandteile | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 184.7 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 56 | | | B | | Oui | | 005 | 196 | | | B | | Oui | | 006 | 100 | | | B | | Oui |
|
|
